Innoviz Technologies | NASDAQ | Israeli Tech · LiDAR for Autonomous Vehicles
Data as of: April 2026 | Primary source: SEC 10-K 2025
Innoviz Technologies (INVZ) is an Israeli LiDAR company for autonomous vehicles, traded on NASDAQ. The company develops LiDAR sensors and perception algorithms for autonomous driving, with key customers including BMW, Volkswagen, and additional automotive manufacturers. Innoviz belongs to the Israeli Deep-Tech commercialisation-stage category — 2025 revenue of $55.1M (+127%), with a net loss of $67.8M. Key observation: material improvement in 2025 — positive gross margins for the first time (23.4%), but still burning ~$48M of cash per year.
| Activity | Characteristic |
|---|---|
| LiDAR Sensors | Core product — InnovizTwo |
| Perception Software | Perception algorithms |
| OEM Programs | BMW, VW, and others |
| Trucking & Industrial | Expansion across segments |
Source: SEC 10-K 2025
This summary is not a recommendation. It is a factual list of key financial metrics.
| Metric | Value |
|---|---|
| Revenue | $55.1M |
| Gross Margin | 23.4% |
| Net Loss | ($67.8M) |
| EPS | ($0.34) |
| Cash | $72.1M |
| Metric | Value |
|---|---|
| Market Cap | $135M |
| Shares | 214.5M |
| Cash Burn | ~$48M/year |
| Cash runway | ~18 months |
Missing data: number of active OEM contracts, backlog value, official 2026 guidance, timing of positive EBITDA.
LiDAR for autonomous vehicles. Competition from Luminar, Cepton, Ouster, and Chinese players (RoboSense, Hesai).
| Competitor | Ticker | Difference |
|---|---|---|
| Luminar | LAZR | Direct US competitor |
| Hesai | HSAI | Major Chinese competitor |
| RoboSense | 2498.HK | Chinese competitor |
| Ouster (Velodyne) | OUST | Industrial-segment competitor |
| Risk | Context |
|---|---|
| Cash burn | $48M/year — cash for 18 months |
| Chinese competition | Hesai, RoboSense at low price points |
| AV adoption delay | If autonomy slows |
| Shareholder dilution | If an additional capital raise is required |
BMW production scale-up, a new OEM contract, GM to 30%+, EBITDA positive within 24 months.
Revenue grows 50-80%, GM 25-30%, additional capital raise in 2027.
OEM delayed, Chinese competition pressures pricing, urgent capital raise required with dilution.
| # | Source | Date | Type |
|---|---|---|---|
| 1 | SEC EDGAR — 20-F 2025 | March 2026 | Official — SEC |
| 2 | IR Innoviz | Quarterly | Official |
| 3 | NASDAQ — INVZ | April 2026 | Official |
Missing: number of active OEM contracts, backlog value, official 2026 guidance, timing of positive EBITDA.
The full Innoviz Technologies (INVZ) analysis is available to Premium members of Bakshi Finance — Family Office.
The analysis includes a professional review across 8 structured sections, 6 charts and a framework of scenarios.
Bakshi Finance | Family Office | All rights reserved 2026